Objective: To study whether the levels of 25-hydroxyvitamin D3 (25-(OH)D3) and Interleukin-1β (IL-1β) are correlated to the eradication and recurrence of helicobacter pylori (Hp) in paediatric patients with Hp infection-related gastritis. Methods: A total of 142 paediatric patients with Hp infection-related gastritis from November 2017 to March 2018 in Baoding Children’s Hospital were selected as study subjectswere selected as study subjects and were followed up for one year. Paediatric patients were grouped and analyzed according to the effect of follow-up treatment and recurrence. Results: The levels of 25-(OH) D3 in the non-eradication group were lower than those in the eradication group and the control group (F=27.087, P<0.05); the levels of IL-1β were higher than those in the eradication group and the control group (F=16.610, P<0.05). Recurrence during follow-up visits: The levels of 25-(OH) D3 in the recurrence group were lower than those in the non-recurrence group and the control group (F=33.837, P<0.05); the levels of IL-1β in the recurrence group were higher than those in the non-recurrence group and the control group (F=7.896, P<0.05). Correlation analysis showed the levels of 25-(OH) D3 and IL-1β in the eradication group and the non-eradication group were negatively correlated (r=-0.232, P<0.05); the levels of 25-(OH) D3 and IL-1β in the recurrence group and the non-recurrence group were negatively correlated (r=-0.225, P<0.05). Conclusion: Relatively high levels of IL-1β may be correlated to the difficulty in eradicating the Hp infection in paediatric patients. Relatively low levels of 25-(OH) D3 may be correlated to the difficulty in eradicating the Hp infection and recurrence in paediatric patients. doi: https://doi.org/10.12669/pjms.36.6.2292 How to cite this:Zhang Y, Bi B, Guo X, Zhang S. Analysis of Eradication, Recurrence and Levels of 25-hydroxyvitamin D3 and Interleukin-1β in paediatric patients with Helicobacter Pylori Infection-related Gastritis. Pak J Med Sci. 2020;36(6):---------. doi: https://doi.org/10.12669/pjms.36.6.2292 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Kawasaki disease (KD) is also called mucocutaneous lymph node syndrome and can affect children aged six months to five years. Kawasaki disease is characterised by a high activation of the immune system and vasculitis and manifests as acute fever, rash and lymphadenectasis. 1 The coronary artery is generally susceptible, and 20%-25% of KD children, who do not receive treatment, have a coronary artery lesion (CAL). This may even lead to a coronary artery aneurysm or thrombus; therefore, KD is an important pathogenic factor for secondary heart disease. 2 Presently, the diagnosis of KD mainly depends on the clinical manifestations, and there is a lack of specific indicators. In addition, CAL can be detected only 2-3 weeks after KD attack. 3 Seeking detection indicators with good specificity is significant for the auxiliary diagnosis of KD, CAL reduction and prognosis improvement. NT-proBNP is a polypeptide that is secreted and synthesised by ventricle muscle cells after an external stimulus, and it is often used to diagnose acute congestive heart failure and assess prognosis. 4,5 Endogenous H 2 S, which is a gas signal transduction molecule, plays an important role in protecting the cardiovascular system and can regulate inflammatory cytokines. 6 IL-6 is an important member of the cytokine family and is also an important indicator reflecting the severity class of heart failure. 7,8 The aim of this study was to determine serum NT-proBNP, H 2 S, and IL-6 levels in children with KD and correlate with the occurrence of CAL.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.